Vancomycin Treatment Is a Risk Factor for Vancomycin-Nonsusceptible Staphylococcus Capitis Sepsis in Preterm Neonates

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2017.03.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Vancomycin Toxicity in Neonates

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2016English

First Report of Spondylodiscitis Due to Vancomycin Heteroresistant Staphylococcus Capitis in Immunocompetent Host

Journal of Infection and Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2014English

Vancomycin Population Pharmacokinetics in Neonates

Clinical Pharmacology and Therapeutics
Pharmacology
2000English

Vancomycin Intoxication in a Preterm Neonate

European Journal of Pediatrics
Child HealthPediatricsPerinatology
1993English

In Vitro Activity of Iclaprim Against Methicillin-Resistant Staphylococcus Aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

Canadian Journal of Infectious Diseases and Medical Microbiology
Infectious DiseasesMicrobiology
2017English

Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococci

English

Monitoring Intraventricular Vancomycin for Ventriculostomy Access Device Infection in Preterm Infants

Child's Nervous System
MedicineChild HealthNeurologyPediatricsPerinatology
2017English

Minocycline Versus Vancomycin for Treatment of Experimental Endocarditis Caused by Oxacillin-Resistant Staphylococcus Aureus.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Vancomycin Pharmacokinetics in Critically Ill Neonates Receiving Extracorporeal Membrane Oxygenation

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy